TELA BIO INC's ticker is TELA and the CUSIP is 872381108. A total of 46 filers reported holding TELA BIO INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $22,684,336 | -21.0% | 2,835,542 | 0.0% | 0.48% | -7.3% |
Q2 2023 | $28,724,040 | -10.8% | 2,835,542 | -6.3% | 0.52% | -17.7% |
Q1 2023 | $32,213,047 | -7.5% | 3,027,542 | 0.0% | 0.63% | -5.1% |
Q4 2022 | $34,816,733 | +35.0% | 3,027,542 | 0.0% | 0.67% | +39.0% |
Q3 2022 | $25,795,000 | +21.5% | 3,027,542 | 0.0% | 0.48% | +24.4% |
Q2 2022 | $21,223,000 | -39.7% | 3,027,542 | 0.0% | 0.38% | -32.6% |
Q1 2022 | $35,210,000 | -9.1% | 3,027,542 | 0.0% | 0.57% | +14.7% |
Q4 2021 | $38,753,000 | -6.3% | 3,027,542 | 0.0% | 0.50% | +9.7% |
Q3 2021 | $41,356,000 | -15.2% | 3,027,542 | 0.0% | 0.45% | -7.9% |
Q2 2021 | $48,774,000 | +8.1% | 3,027,542 | 0.0% | 0.49% | +16.8% |
Q1 2021 | $45,110,000 | -0.9% | 3,027,542 | 0.0% | 0.42% | +6.0% |
Q4 2020 | $45,534,000 | -9.1% | 3,027,542 | 0.0% | 0.40% | -36.7% |
Q3 2020 | $50,076,000 | +27.6% | 3,027,542 | 0.0% | 0.63% | +13.9% |
Q2 2020 | $39,237,000 | +65.7% | 3,027,542 | 0.0% | 0.55% | +38.7% |
Q1 2020 | $23,675,000 | -39.6% | 3,027,542 | 0.0% | 0.40% | -28.9% |
Q4 2019 | $39,207,000 | – | 3,027,542 | – | 0.56% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Essex Woodlands Management, Inc. | 1,580,089 | $23,543,000 | 3.68% |
Opaleye Management Inc. | 365,000 | $5,439,000 | 0.80% |
JACOB ASSET MANAGEMENT OF NEW YORK LLC | 103,000 | $1,535,000 | 0.59% |
Orbimed Advisors | 3,027,542 | $45,110,000 | 0.42% |
COWEN AND COMPANY, LLC | 401,376 | $5,981,000 | 0.41% |
SANDERS MORRIS HARRIS LLC | 122,558 | $1,826,000 | 0.39% |
RTW INVESTMENTS, LP | 1,382,343 | $20,597,000 | 0.32% |
PURA VIDA INVESTMENTS, LLC | 421,202 | $6,276,000 | 0.18% |
WMS Partners, LLC | 27,300 | $407,000 | 0.09% |
ARMISTICE CAPITAL, LLC | 250,000 | $3,725,000 | 0.09% |